Abstract
In vitro maturation (IVM) of human oocytes is an attractive alternative to conventional assisted reproductive technology (ART) treatment, as it involves no or minimal ovarian stimulation. Currently, commercialized media specifically designed for IVM are often used. These media are expensive, have limited shelf life, and must be ordered in advance. If standard culture media can be used in place of the specialized IVM media, it would simplify management and make IVM more feasible and more widely employed in ART centers around the world, especially in developing countries where resources are scarce. This study was, therefore, conducted to test the hypothesis that blastocyst medium was as good as commercial IVM medium to support maturation and developmental competence of human immature oocytes as previously shown in the mouse system. Immature oocytes were obtained by needle aspiration from 89 pregnant women during cesarean deliveries between April 2012 and February 2013. Sibling oocytes were allocated to Sage IVM media (512 oocytes) or blastocyst medium (520 oocytes) and assessed for maturation 36 hours later. Mature oocytes were inseminated by intracytoplasmic sperm injection and cultured up to 144 hours. There was no difference in maturation rate (65.0% vs 68.7%; P = .218) or fertilization rate (66.9% vs 66.4%; P = .872) of oocytes matured in vitro in both media. There was also no difference in the formation of good-quality blastocysts (46.6% vs 45.9%; P = .889) in the 2 groups. Further study should be done to ascertain implantation and pregnancy potential of these embryos.
Similar content being viewed by others
References
The Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril. 2013; 99(3):663–666.
Gremeau AS, Andreadis N, Fatum M, et al. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril. 2012;98(2): 355–360.
Blanco MR, Demyda S, Moreno Millan M, Genero E. Developmental competence of in vivo and in vitro matured oocytes: a review. Biotechnol Mol Biol Rev. 2011;6(7):155–165.
Kim M, Hong SJ, Lee JH, Min CK, Hwang KJ, Park RW. Comparison of in vitro maturation media of immature oocytes: the effectiveness of blastocyst culture medium. Fertil Steril. 2011; 95(2):554–557.
Son WY, Chung JY, Demirtas E, et al. Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod Biomed Online. 2008;17(1):59–67.
Soderstrom-Antilla V, Makinen S, Tuuri T, Suikkari AM. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod. 2005;20(6): 1534–1540.
Gardner DK, Lane M, Spitzer A, Batt PA. Enhanced rates of cleavage and development for sheep zygotes cultured to the blastocyst stage in vitro in the absence of serum and somatic cells: amino acids, vitamins, and culturing embryos in groups stimulate development. Biol Reprod. 1994;50(2):390–400.
Meintjes M. Media composition: macromolecules and embryo growth. Methods Mol Biol. 2012;912:107–127.
Hennet ML, Cambell CMH. The antral follicle: a microenvironment for oocyte differentiation. Int J Dev Biol. 2012;56(10–12): 819–831.
Gandolfi TA, Gandolfi F. The maternal legacy to the embryo: cytoplasmic components and their effects on early development. Theriogenology. 2001;55(6):1255–1276.
Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril. 1994; 62(2):353–362.
de Araujo CH, Nogueira D, de Araujo MC, Martins Wde P, Ferriani RA, dos Reis RM. Supplemented tissue culture medium 199 is a better medium for in vitro maturation of oocytes from women with polycystic ovary syndrome women than human tubal fluid. Fertil Steril. 2009;91(2):509–513.
Son WY, Yoon SH, Lee SW, Ko Y, Yoon HG, Lim JH. Blastocyst development and pregnancies after IVF of mature oocytes retrieved from un-stimulated patients with PCOS after in-vivo HCG priming: case report. Hum Reprod. 2002;17(1):134–136.
Filali M, Hesters L, Fanchin R, Tachdjian G, Frydman R, Frydman N. Retrospective comparison of two media for in vitro maturation of oocytes. Reprod Biomed Online. 2008;16(2): 250–256.
Cobo AC, Requena A, Neuspiller F, et al. Maturation in vitro of human oocytes from unstimulated cycles: selection of the optimal day for ovum retrieval based on follicular size. Hum Reprod. 1999;14(7):1864–1868.
Barnes F, Kausche A, Tiglias J, Wood C, Wilton L, Trounson A. Production of embryos from in vitro matured primary human oocytes. Fertil Steril. 1996;65(6):1151–1156.
Smith SD, Mikkelsen AL, Lindenberg S. Development of human oocytes mature in vitro for 28 or 36 hours. Fertil Steril. 2000; 73(3):541–544.
Walls M, Junk S, Ryan JP, Hart R. IVF versus ICSI for the fertilization of in-vitro matured human oocytes. Reprod Biomed Online. 2012;25(6):603–607.
Son WY, Lee SY, Lim JH. Fertilization, cleavage and blastocyst development according to the maturation timing of oocytes in in vitro maturation cycles. Hum Reprod. 2005;20(11):3204–3207.
Anckaert E, De Rycke M, Smitz J. Culture of oocytes and risk of imprinting defects. Hum Reprod Update. 2013;19(1):52–66.
Fadini R, Renzini MM, Dal Canto M, et al. Oocyte in vitro maturation in normo-ovulatory women. Fertil Steril. 2013; 99(5):1162–1169.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pongsuthirak, P., Songveeratham, S. & Vutyavanich, T. Comparison of Blastocyst and Sage Media for In Vitro Maturation of Human Immature Oocytes. Reprod. Sci. 22, 343–346 (2015). https://doi.org/10.1177/1933719114542027
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719114542027